NCT06126913View on ClinicalTrials.gov

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV

NARecruitingINTERVENTIONAL
Enrollment

2,720

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
HIV InfectionsHiv
Interventions
OTHER

Community Antiretroviral Therapy

Newly diagnosed individuals (diagnosed in the prior 6 months) at intervention sites will be offered community ART delivery on a rolling basis during the enrollment window, initiating individuals into groups as close to their date of diagnosis as possible. Newly enrolled individuals will join existing community ART delivery groups, or when a new group is needed based on group size or geographic location, a new group will be formed.

Trial Locations (1)

Unknown

RECRUITING

Infectious Diseases Institute, Makerere University, Kampala

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Washington

OTHER